Literature DB >> 21073838

Nemaline bodies as unique pathological feature in the course of treated dermatomyositis.

F Letournel1, C Le Clec'h, A Croué, P Marcorelles, C Lavigne, I Pénisson-Besnier.   

Abstract

Dermatomyositis was diagnosed on clinical and muscle histological criteria in a 42-year-old woman. Despite treatment, the patient complained of deterioration of her muscle condition. Since her symptoms were discordant with the rest of the data, muscle biopsy was performed and disclosed rod-bearing non-atrophic fibers as the unique and predominant pathological feature. Their significance is examined in this paper.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21073838     DOI: 10.5414/npp29357

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  4 in total

Review 1.  HIV-related neuromuscular diseases: nemaline myopathy, amyotrophic lateral sclerosis and bibrachial amyotrophic diplegia.

Authors:  L P Rowland
Journal:  Acta Myol       Date:  2011-06

2.  Unilateral heliotrope rash in juvenile dermatomyositis: an unusual presentation of an underlying serious disease.

Authors:  Ghada Al-Janobi; Hisham Alkhalidi; Mohammed A Omair
Journal:  Case Rep Rheumatol       Date:  2014-12-22

3.  Recurrent Bilateral Focal Myositis.

Authors:  Hiroko Nagafuchi; Hiromasa Nakano; Seido Ooka; Yukiko Takakuwa; Hidehiro Yamada; Mamoru Tadokoro; Sadatomo Shimojo; Shoichi Ozaki
Journal:  Intern Med       Date:  2016-11-15       Impact factor: 1.271

Review 4.  Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases.

Authors:  Lukas J Schnitzler; Tobias Schreckenbach; Aleksandra Nadaj-Pakleza; Werner Stenzel; Elisabeth J Rushing; Philip Van Damme; Andreas Ferbert; Susanne Petri; Christian Hartmann; Antje Bornemann; Andreas Meisel; Jens A Petersen; Thomas Tousseyn; Dietmar R Thal; Jens Reimann; Peter De Jonghe; Jean-Jacques Martin; Peter Y Van den Bergh; Jörg B Schulz; Joachim Weis; Kristl G Claeys
Journal:  Orphanet J Rare Dis       Date:  2017-05-11       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.